USD 1.0 billion
Report ID:
SQMIG35A2495 |
Region:
Global |
Published Date: February, 2025
Pages:
157
|Tables:
64
|Figures:
75
Insulin Storage Devices Market size was valued at USD 1.0 billion in 2023 and is poised to grow from USD 1.08 billion in 2024 to USD 1.95 billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).
The market's growth is propelled by the escalating occurrence of diabetes and the increasing uptake of advanced insulin delivery devices. Furthermore, the surge in demand for sophisticated storage solutions emerges as a pivotal growth catalyst. The advent of insulin pumps has precipitated a need for enduring insulin-carrying solutions, fostering growth prospects during the forecast timeframe. Urbanization, sedentary lifestyles, and dietary shifts have contributed to a surge in obesity, a significant driver of diabetes.
Obesity, intricately linked to diabetes, is anticipated to afflict one billion individuals globally by 2030, per the World Obesity Federation. The ascent of refined and processed foods has adversely impacted consumer well-being, causing diabetes due to unhealthy dietary choices. This surge in diabetes incidence is poised to amplify the demand for insulin storage devices.
Notably, individuals with type 1 diabetes, who produce limited or no insulin, necessitate lifelong treatment and precise storage solutions. Temperature fluctuations can impair insulin efficacy, motivating the need for proper storage, especially for the young population, where over 1.52 million individuals with type 1 diabetes are under 20 years old, as per the International Diabetes Federation.
US Insulin Storage Devices Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 1.0 billion
Largest Segment
Type 1 Diabetes
Fastest Growth
Type 1 Diabetes
Growth Rate
7.7% CAGR
To get more reports on the above market click here to Buy The Report
Global Insulin Storage Devices Market is segmented by Product Type, Patient Type and region. Based on Product Type, the market is segmented into Insulated Kits and Battery Operated Insulin Storage Devices. Based on Patient Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
In terms of product types, the market is categorized into insulated kits and battery-operated devices. Notably, battery-operated devices took precedence, capturing a substantial revenue share of 61.09% in 2022. The ascendancy of battery-operated coolers stems from their rising popularity among individuals with diabetes, owing to their mobility and precise cooling capabilities. These devices ensure the consistent temperature maintenance of insulin vials, pens, and cartridges, a feature particularly advantageous during travel, thus enhancing their overall practicality.
Simultaneously, the insulated kits segment held considerable market sway in 2022 and is projected to exhibit noteworthy growth at a commendable Compound Annual Growth Rate (CAGR) over the forecast period. This segment's expansion is driven by its affordability and user-friendly nature. The category of insulin kits encompasses cooling wallets, cooling pouches, and insulated cooling bags. Among these subcategories, cooling wallets emerge as the dominant choice, largely due to their widespread availability and popularity among older patient demographics.
Segmented by patient type, the market is bifurcated into type 1 and type 2 diabetic patients. Remarkably, the type 1 diabetes segment took the lead, commanding a substantial market share of 81.81% in 2022. This prominence of type 1 patients is attributed to their heightened insulin requirements and their willingness to adopt insulin delivery devices. For instance, in the UK alone, there are more than 400,000 individuals grappling with type 1 diabetes, a group that includes roughly 29,000 children. Given that type 1 diabetes necessitates lifelong management, continuous blood glucose monitoring, and insulin administration, these individuals rely on insulin packs for their day-to-day activities.
Concurrently, the type 2 diabetes segment is in rapid expansion mode, primarily due to the exponential increase in patient numbers. To elucidate, as per the World Health Organization (WHO), diabetes afflicts over 422 million individuals globally, with a substantial concentration residing in low- and middle-income nations. Shockingly, diabetes is directly accountable for around 1.5 million deaths annually. Notably, type 2 diabetes, often associated with lifestyle choices, is predominant among adults and working individuals. As this patient group generally prefers long-term insulin administration over frequent pharmacy visits, there is a projected surge in demand for insulin storage devices in the forecast period.
To get detailed analysis on other segments, Request For Free Sample Report
Notably, North America commands a prominent position in the market due to its substantial patient base and favorable reimbursement policies. The region secured a substantial market share of 45.67% in 2022. This is underpinned by Canada's noteworthy contribution, where over 3 million individuals are grappling with diabetes, with the prevalence rate growing by approximately 3.3% annually, accounting for the elderly population. Furthermore, escalating healthcare expenditures by consumers in North America are propelling market growth.
Anticipated to exhibit robust growth during the forecast period, the Asia Pacific region is poised to be a key growth driver. This growth is fueled by the surge in disease prevalence and heightened awareness campaigns promoting effective insulin use and storage. Government initiatives and educational programs further contribute to propelling the market's expansion. Remarkably, Asia hosts nearly 60% of the global diabetes population. With rapid economic development and urbanization, the region is witnessing a significant increase in working-age individuals affected by diabetes, consequently driving demand for insulin storage devices.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Diabetes Prevalence
Advancements in Insulin Delivery
Growing Awareness of Diabetes Management
Limited Access in Low-Income Countries
Lack of Awareness
Complexity of Devices
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global insulin storage devices market is characterized by a blend of established healthcare companies, innovative startups, and technological pioneers. Key players in the market include prominent medical device manufacturers, pharmaceutical companies, and specialized firms dedicated to diabetes management solutions. These industry leaders leverage their extensive expertise, distribution networks, and research capabilities to offer a diverse range of insulin storage devices that cater to the evolving needs of patients.
Innovation remains a driving force, as companies continuously strive to enhance the usability, convenience, and technological sophistication of their products. This includes the development of smart insulin storage devices with features like temperature monitoring, mobile app integration, and data connectivity. Furthermore, collaborations between pharmaceutical giants and device manufacturers are fostering cross-industry synergies, resulting in advanced solutions that address the unique requirements of diabetes patients.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global insulin storage devices market analysis, the global insulin storage devices market stands at the forefront of addressing the critical needs of diabetes management. With rising diabetes prevalence and evolving patient preferences, the market is witnessing a shift toward innovative, user-friendly, and technologically advanced storage solutions. The dominance of battery-operated devices and the escalating demand for insulin storage among type 1 diabetic patients underscore the market's growth trajectory.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 1.0 billion |
Market size value in 2032 | USD 1.95 billion |
Growth Rate | 7.7% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Insulin Storage Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Insulin Storage Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Insulin Storage Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Insulin Storage Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Insulin Storage Devices Market size was valued at USD 941.34 Million in 2023 and is poised to grow from USD 1018.53 Million in 2024 to USD 1913.34 Million by 2032, growing at a CAGR of 8.20% during the forecast period (2025-2032).
The competitive landscape of the global insulin storage devices market is characterized by a blend of established healthcare companies, innovative startups, and technological pioneers. Key players in the market include prominent medical device manufacturers, pharmaceutical companies, and specialized firms dedicated to diabetes management solutions. These industry leaders leverage their extensive expertise, distribution networks, and research capabilities to offer a diverse range of insulin storage devices that cater to the evolving needs of patients. 'ReadyCare, LLC (USA)', 'DISONCARE (China)', 'Medicool (China)', 'Tawa Outdoor (China)', 'Cooluli (France)', 'Arkray, Inc. (Japan)', 'Zhengzhou Olive Electronic Technology Co., Ltd. (China)', 'Zhengzhou Defrigus Electric Device Co., Ltd. (China)', 'COOL Sarl-FR (France)', 'AfriMedix (South Africa)', 'Insulet Corporation (USA)', 'BD (USA)', 'Medtronic (Ireland)', 'Novo Nordisk (Denmark)', 'Sanofi (France)', 'Roche (Switzerland)', 'Ypsomed (Switzerland)', 'Terumo (Japan)', 'Abbot Diabetes Care (USA)', 'Nipro Corporation (Japan)'
The increasing global incidence of diabetes, particularly type 1 and type 2, is a primary driver for insulin storage devices as these devices are essential for effective insulin management.
Smart and Connected Devices: The integration of IoT technology is leading to the development of smart insulin storage devices that offer features like temperature monitoring, reminders, and connectivity with smartphones.
Notably, North America commands a prominent position in the market due to its substantial patient base and favorable reimbursement policies. The region secured a substantial market share of 45.67% in 2022. This is underpinned by Canada's noteworthy contribution, where over 3 million individuals are grappling with diabetes, with the prevalence rate growing by approximately 3.3% annually, accounting for the elderly population. Furthermore, escalating healthcare expenditures by consumers in North America are propelling market growth.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2495
[email protected]
USA +1 351-333-4748